scholarly article | Q13442814 |
P2093 | author name string | Rong Zhu | |
Qing Xu | |||
Ning Tan | |||
Songqing He | |||
Hongguang Zhu | |||
Xiaojia Liu | |||
Hongtao Liao | |||
Liping Zou | |||
Guangdong Pan | |||
P2860 | cites work | Global cancer statistics, 2012 | Q27860501 |
Targeting CDK4 and CDK6: From Discovery to Therapy | Q28082912 | ||
Recycling the cell cycle: cyclins revisited | Q28240732 | ||
Sirtuin 3 enhanced drug sensitivity of human hepatoma cells through glutathione S-transferase pi 1/JNK signaling pathway | Q28468627 | ||
Cyclin-dependent kinases: engines, clocks, and microprocessors | Q29614786 | ||
Hepatocellular carcinoma | Q29616359 | ||
Glutathione transferases | Q29616501 | ||
Recycling the Cell Cycle | Q29999767 | ||
A prospective study of tumor suppressor gene methylation as a prognostic biomarker in surgically resected stage I to IIIA non-small-cell lung cancers. | Q34048874 | ||
GSTP1 arrests bladder cancer T24 cells in G0/G1 phase and up-regulates p21 expression | Q34415219 | ||
Structural studies with inhibitors of the cell cycle regulatory kinase cyclin-dependent protein kinase 2. | Q34792851 | ||
A cytotoxic protein (BF-CT1) purified from Bungarus fasciatus venom acts through apoptosis, modulation of PI3K/AKT, MAPKinase pathway and cell cycle regulation | Q34974979 | ||
GSTP1 negatively regulates Stat3 activation in epidermal growth factor signaling. | Q36621556 | ||
Established and novel Cdk/cyclin complexes regulating the cell cycle and development. | Q37883204 | ||
Acquired radioresistance of cancer and the AKT/GSK3β/cyclin D1 overexpression cycle | Q37924479 | ||
Cyclin-dependent kinase inhibitor p21(Waf1): contemporary view on its role in senescence and oncogenesis. | Q38027908 | ||
p27(Kip1) signaling: Transcriptional and post-translational regulation. | Q38567920 | ||
CDK6-a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation | Q38616175 | ||
HBx drives alpha fetoprotein expression to promote initiation of liver cancer stem cells through activating PI3K/AKT signal pathway | Q38727305 | ||
GSTP1 Methylation and Protein Expression in Prostate Cancer: Diagnostic Implications | Q41339288 | ||
Metabolic tumor volume predicts disease progression and survival in patients with squamous cell carcinoma of the anal canal. | Q46196027 | ||
Reduction of GSTP1 expression by DNA methylation correlates with clinicopathological features in pituitary adenomas | Q46470681 | ||
Nomenclature for mammalian soluble glutathione transferases | Q46884286 | ||
Immunohistochemical expression of pi class glutathione S-transferase and alpha-fetoprotein in hepatocellular carcinoma and chronic liver disease | Q75233807 | ||
Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma | Q81176240 | ||
[A study on the methylation and glutathione S-transferases P1 activity in hepatocellular carcinoma tissues] | Q82633205 | ||
Multidrug resistance-associated biomarkers PGP, GST-pi, Topo-II and LRP as prognostic factors in primary ovarian carcinoma | Q84450734 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | phosphorylation | Q242736 |
P304 | page(s) | 8957-8971 | |
P577 | publication date | 2017-12-19 | |
P1433 | published in | Oncotarget | Q1573155 |
P1476 | title | High GSTP1 inhibits cell proliferation by reducing Akt phosphorylation and is associated with a better prognosis in hepatocellular carcinoma. | |
P478 | volume | 9 |